MarketPeel
Head of R&D, CMO
Thu, Jun 11, 2026
Jun 11
sold $617.04k of SNDX
34,280 shares @ $18.00
Decreased holdings by -36.00%
2nd largest trade (out of 9)
Planned (10b5-1)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 16,537 options to purchase shares of common stock that are vested and immediately exercisable and a total of 289,413 options to purchase shares of common stock that have not yet vested.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 8% below 200-day moving average
Small Cap stock — insider trades carry more weight
SNDXSyndax Pharmaceuticals Inc
HealthcareBiotechnology
1D0.00%
1W-0.56%
1M-5.57%
3M-1.26%
6M
1Y

Recent insider activity at SNDX

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback